These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 24095974

  • 1. Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.
    Gopal P, Yopp AC, Waljee AK, Chiang J, Nehra M, Kandunoori P, Singal AG.
    Clin Gastroenterol Hepatol; 2014 May; 12(5):870-7. PubMed ID: 24095974
    [Abstract] [Full Text] [Related]

  • 2. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA, Lee JS, Jung ES, Kim JY, Bae WK, Kim NH, Moon YS.
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [Abstract] [Full Text] [Related]

  • 3. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
    Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB.
    Hepatology; 2002 Aug; 36(2):410-7. PubMed ID: 12143050
    [Abstract] [Full Text] [Related]

  • 4. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
    Yang JD, Dai J, Singal AG, Gopal P, Addissie BD, Nguyen MH, Befeler AS, Reddy KR, Schwartz M, Harnois DM, Yamada H, Gores GJ, Feng Z, Marrero JA, Roberts LR.
    Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1085-1092. PubMed ID: 28258053
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN, Kim BK, Kim SU, Park JY, Ahn SH, Han KH, Kim DY.
    Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
    [Abstract] [Full Text] [Related]

  • 6. Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System.
    Tayob N, Richardson P, White DL, Yu X, Davila JA, Kanwal F, Feng Z, El-Serag HB.
    BMC Med Res Methodol; 2018 Jan 04; 18(1):1. PubMed ID: 29301497
    [Abstract] [Full Text] [Related]

  • 7. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS, Wu YC, Tung SY, Wei KL, Hsieh YY, Huang HC, Chen WM, Shen CH, Lu CH, Wu CS, Tsai YH, Huang YH.
    Am J Gastroenterol; 2015 Jun 04; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.
    Liu D, Luo Y, Chen L, Chen L, Zuo D, Li Y, Zhang X, Wu J, Xi Q, Li G, Qi L, Yue X, Zhang X, Sun Z, Zhang N, Song T, Lu W, Guo H.
    Cancer Biol Med; 2021 Feb 15; 18(1):256-270. PubMed ID: 33628599
    [Abstract] [Full Text] [Related]

  • 9. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
    Xiao J, Long F, Peng T, Hu LB, Cai H, Chen R, Chen WL.
    Eur Rev Med Pharmacol Sci; 2019 Apr 15; 23(8):3302-3310. PubMed ID: 31081083
    [Abstract] [Full Text] [Related]

  • 10. Improving screening for hepatocellular carcinoma by incorporating data on levels of α-fetoprotein, over time.
    Lee E, Edward S, Singal AG, Lavieri MS, Volk M.
    Clin Gastroenterol Hepatol; 2013 Apr 15; 11(4):437-40. PubMed ID: 23247324
    [Abstract] [Full Text] [Related]

  • 11. Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies.
    Tayob N, Corley DA, Christie I, Almers L, Rahal AK, Richardson P, White DL, Davila J, Kanwal F, El-Serag HB.
    Clin Gastroenterol Hepatol; 2021 Jul 15; 19(7):1443-1450.e6. PubMed ID: 32768590
    [Abstract] [Full Text] [Related]

  • 12. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W.
    PLoS One; 2015 Jul 15; 10(5):e0127518. PubMed ID: 25996938
    [Abstract] [Full Text] [Related]

  • 13. Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.
    Tzartzeva K, Obi J, Rich NE, Parikh ND, Marrero JA, Yopp A, Waljee AK, Singal AG.
    Gastroenterology; 2018 May 15; 154(6):1706-1718.e1. PubMed ID: 29425931
    [Abstract] [Full Text] [Related]

  • 14. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
    El-Serag HB, Kanwal F, Davila JA, Kramer J, Richardson P.
    Gastroenterology; 2014 May 15; 146(5):1249-55.e1. PubMed ID: 24462733
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma.
    Wang Q, Chen Q, Zhang X, Lu XL, Du Q, Zhu T, Zhang GY, Wang DS, Fan QM.
    World J Gastroenterol; 2019 Sep 28; 25(36):5515-5529. PubMed ID: 31576097
    [Abstract] [Full Text] [Related]

  • 16. Validity of alpha fetoprotein for diagnosis of hepatocellular carcinoma in cirrhosis.
    Sarwar S, Khan AA, Tarique S.
    J Coll Physicians Surg Pak; 2014 Jan 28; 24(1):18-22. PubMed ID: 24411536
    [Abstract] [Full Text] [Related]

  • 17. GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis.
    Singal AG, Tayob N, Mehta A, Marrero JA, El-Serag H, Jin Q, Saenz de Viteri C, Fobar A, Parikh ND.
    Hepatology; 2022 Mar 28; 75(3):541-549. PubMed ID: 34618932
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY, Jung SW, Kim HY, Kim M, Kim Y, Kim DG, Oh EJ.
    World J Gastroenterol; 2013 Jan 21; 19(3):339-46. PubMed ID: 23372355
    [Abstract] [Full Text] [Related]

  • 19. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-Related Mortality in Patients With Cirrhosis.
    Moon AM, Weiss NS, Beste LA, Su F, Ho SB, Jin GY, Lowy E, Berry K, Ioannou GN.
    Gastroenterology; 2018 Oct 21; 155(4):1128-1139.e6. PubMed ID: 29981779
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
    Worland T, Harrison B, Delmenico L, Dowling D.
    J Gastrointest Cancer; 2018 Dec 21; 49(4):476-480. PubMed ID: 28920172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.